Status:
COMPLETED
Towards Personalized Medicine for OCD
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Obsessive compulsive disorder (OCD) is one of the most disabling anxiety disorders occurring in about 2 out of a 100 adults. Untreated, OCD is a chronic and deteriorating condition, negatively impacti...
Detailed Description
Introduction Anxiety disorders are some of the most prevalent mental illnesses affecting 350.000-400.000 Danes every year. Obsessive compulsive disorder (OCD) is one of the most disabling anxiety diso...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- have OCD as their primary diagnosis
- are between 18-65 years
- are free of alcohol and substance abuse
- are not receiving any other psychotherapy during the study
- are medication-free or stabilized on psychotropic medication
- speak and understand Danish
- provide written consent
Exclusion
Key Trial Info
Start Date :
March 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2025
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT03852186
Start Date
March 2 2019
End Date
June 25 2025
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Copenhagen
Copenhagen, Denmark, 2100